All articles by Phillip Broadwith – Page 14
-
Business
EU chemicals regulator scolded over animal testing
Ombudsman says ECHA isn’t doing enough to require alternative, non-animal methods
-
Business
Consumer products firms fined for French price fixing
€950m fines for ‘friends clubs’ that pushed up prices for home and personal care products
-
BusinessSolving iron’s solubility problem
Technology profile: MRC Human Nutrition Research - anaemia supplements with fewer side effects
-
Business
Otsuka to buy neurology specialist Avanir
$3.5bn deal adds to Otsuka’s mental health portfolio and strengthens its US presence
-
Business
UCB sells speciality generics subsidiary
Firm will use $1.5bn proceeds to reduce debt and concentrate on developing new drugs in neurology and immunology
-
Business
Syngenta to cut or relocate 1800 jobs in 2015
Global reorganisation plan will involve ‘consolidation’ of R&D facilities
-
Business
Labcorp to buy Covance and enter contract research
Firm wants to diversify away from diagnostics, but law firm investigation suggests investors are unconvinced of the deal’s value
-
Business
Perrigo to buy Omega Pharma for €3.6bn
Deal strengthens Perrigo’s over-the-counter portfolio and pushes strongly into Europe
-
Business
Lanxess to cut 1000 jobs over two years
Agrium also cutting 500 positions and divesting underperforming business segments
-
Business
Chinese buyer resurrects US Boehringer plant
UniTao will take over manufacturing site scheduled for closure, saving over 200 jobs
-
Business
EU warns DuPont and Honeywell over green refrigerants
Commission thinks cooperation may have been anti-competitive
-
Business
Judge slashes fines in drug safety case
Takeda and Eli Lilly’s $9 billion damages in diabetes trial reduced to $38 million
-
Business
Platform to expand in agrochemicals by buying Arysta
Business will be integrated with previous acquisitions for a broad crop protection portfolio
-
BusinessCHF3bn redevelopment for Roche’s Basel site
New buildings will move employees out of rented office space
-
Business
Amgen stacks up additional job cuts
Up to 1100 more staff face redundancy in ongoing restructuring plan
-
Business
AbbVie backs out of Shire deal
Treasury rule changes make inversion ‘too uncertain’ and remove financial benefits
-
Business
Endo outbids QLT for Auxilium merger
Biotech backs out of Canadian deal in favour of increased $2.6bn bid from Endo
-
Business
EMA finalises trial transparency rules
Researcher access reinstated, but company redaction rights may cause issues
-
Business
Actavis boosts antibiotics with Durata buyout
$820 million deal gives Actavis control of newly-approved intravenous antibiotic
-
Business
Becton Dickinson to buy CareFusion for $12bn
Medical devices merger continues consolidation trend